We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

131 hedge funds and large institutions have $423M invested in Immunogen Inc in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 50 increasing their positions, 37 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

179% more call options, than puts

Call options by funds: $11.2M | Put options by funds: $4.03M

35% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 37

7% less funds holding

Funds holding: 141131 (-10)

30% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 30

47% less capital invested

Capital invested by funds: $795M → $423M (-$372M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
131
Holders Change
-10
Holders Change %
-7.09%
% of All Funds
3.49%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
21
Increased
50
Reduced
37
Closed
30
Calls
$11.2M
Puts
$4.03M
Net Calls
+$7.2M
Net Calls Change
+$2.39M
Name Holding Trade Value Shares
Change
Change in
Stake
Royal Bank of Canada
76
Royal Bank of Canada
Ontario, Canada
$174K +$95.8K +10,481 +58%
Bank of America
77
Bank of America
North Carolina
$171K -$1.35M -148,096 -84%
Comerica Bank
78
Comerica Bank
Texas
$166K +$127K +13,868 +104%
JMPWA
79
JP Morgan Private Wealth Advisors
California
$153K +$43.8K +4,786 +24%
Neuberger Berman Group
80
Neuberger Berman Group
New York
$152K +$1.5K +164 +0.7%
AQR Capital Management
81
AQR Capital Management
Connecticut
$140K -$1.16K -127 -0.5%
VKH
82
Virtu KCG Holdings
New York
$128K -$83K -9,081 -30%
SG Americas Securities
83
SG Americas Securities
New York
$123K +$96.2K +10,523 +109%
TRCT
84
Tower Research Capital (TRC)
New York
$114K +$167K +18,266 +4,533%
FBA
85
Front Barnett Associates
Illinois
$111K -$22.9K -2,500 -12%
William Blair & Company
86
William Blair & Company
Illinois
$106K -$55K -6,013 -25%
AT
87
Arden Trust
Delaware
$103K -$8.4K -919 -5%
Principal Financial Group
88
Principal Financial Group
Iowa
$97K -$17.2K -1,885 -11%
CCMH
89
Cornerstone Capital Management Holdings
New York
$88K +$127K +13,900 +2,317%
PCM
90
Prelude Capital Management
New York
$88K +$133K +14,500 New
M&T Bank
91
M&T Bank
New York
$86K -$44.5K -4,870 -26%
Creative Planning
92
Creative Planning
Kansas
$86K +$722 +79 +0.6%
N
93
Nuveen
North Carolina
$78K -$3.56K -389 -3%
Legal & General Group
94
Legal & General Group
United Kingdom
$77K
Commonwealth Equity Services
95
Commonwealth Equity Services
Massachusetts
$76K +$4.07K +445 +4%
MA
96
MUFG Americas
New York
$61K +$91.4K +10,000 New
Simplex Trading
97
Simplex Trading
Illinois
$54K +$80.5K +8,803 New
LTFS
98
Ladenburg Thalmann Financial Services
Florida
$44K +$37.5K +4,101 +163%
WT
99
Whittier Trust
California
$42K
PNC Financial Services Group
100
PNC Financial Services Group
Pennsylvania
$29K +$4.02K +440 +10%

IMGN Hedge Fund Activity: Q4 2014 in Review

131 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2014, worth a combined $423M — down 47% from $795M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of IMGN and 21 opened new positions — a net loss of 9 holders — while 37 trimmed existing stakes and 50 added.

The largest buyer was Millennium Management, adding an estimated $12.3M. The largest seller was First Trust Advisors, exiting entirely with an estimated $61.5M sold.

  • 131 institutional investors held Immunogen Inc (IMGN) as of Q4 2014, down from 141 in Q3 2014.
  • Funds reported $423M of Immunogen Inc stock for Q4 2014, down 47% quarter-over-quarter.
  • 21 funds opened new Immunogen Inc positions in Q4 2014 and 30 closed out, a net change of -9 holders.
  • The largest Immunogen Inc buyer in Q4 2014 was Millennium Management, an estimated $12.3M added.
  • The largest Immunogen Inc seller in Q4 2014 was First Trust Advisors, an estimated $61.5M sold.

Based on aggregated 13F filings for Q4 2014.